Companies in the diabetes sector developing innovative solutions and technologies.
Explore 46 recently funded diabetes companies with verified founder contact information and fundraising data.
Sava Technology creates under-skin sensors to monitor glucose, lactate, and ketones continuously, providing real-time health data.
Apollon develops noninvasive continuous glucose monitoring systems.
Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
Biotts develop proprietary drug delivery technologies and drug formulas in the field of diabetology.
KalVista Pharmaceuticals focuses on developing oral medicines, particularly for managing hereditary angioedema.
MyWay Digital Health is a comprehensive online self management platform.
Bioxytech Retina provides the research of optical device to diagnose diabetes, using non-invasive imaging technology.
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics.
Rezolute is a clinical-stage biopharma specializing in the development of drug therapies for patients with metabolic and orphan diseases.
Pacific Diabetes Technologies develops hollow glucose sensor devices for continuous glucose monitoring and insulin delivery.
Health2Sync develops systems that transform smartphones into legacy medical devices and smart health monitoring machines.
Diabet' offers care centers and digital tools to streamline care delivery and clinical coordination for diabetic patients.
Dia Beta Labs is the research group's official commercial vehicle, advancing lead assets into late-stage preclinical development.
G.I. Windows is a clinical-stage company developing the first fundamental breakthrough in surgical anastomotic technology.
Glooko provides digital health platforms and data management tools for diabetes care.
Orpyx Medical Technologies develops sensor-based technologies and self-monitoring devices in medical and athletic spaces.
Olakino is an exercise app that helps people suffering from diabetes to exercise in a safe way and to lower their insulin resistance.
DreaMed Diabetes offers AI solutions and personalized support for optimized insulin therapy.
Diatech Diabetes is a developer of monitoring systems to personalize insulin delivery for patients with diabetes.
The first effortless continuous molecular tracker unlocking human perfomance
Our HabitNu program provides support-based diabetes management.
Hedia is a personal diabetes-assistant, based on artificial intelligence.
The most effective Digital Therapy to reverse metabolic dysfunction based on mobile technology, biosensors, AI and behavioral science.
moveo is a personalized health platform and an app that tracks neurological health.
The diabetes sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Diabetes companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The diabetes sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 46 diabetes companies tracked in the VCBacked database.
Companies in the diabetes sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting diabetes companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked